Evaluating The Impact of A Mental Health App on Depression and Resilience Among Medical Students
1 other identifier
interventional
220
1 country
1
Brief Summary
This randomized controlled trial aims to determine whether access to a mental health app improves resilience and reduces depressive symptoms among medical students over a three-month period. Compared to the control group, researchers hypothesized that medical students in the intervention group are expected to show:
- Significant reductions in depressive symptoms and greater improvements in resilience after three months of usage.
- Significant reduction in thoughts of self-harm and anxiety, and improvement in self-esteem after three months of usage. Researchers will compare two groups to evaluate the app's impact on wellbeing:
- Intervention group: Receives immediate full access to the mental health app.
- Control group: Receives basic, without full access to the mental health app. Participants will explore and experience the various features offered in the mental health app over a three-month period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedStudy Start
First participant enrolled
February 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
February 13, 2026
February 1, 2026
5 months
February 2, 2026
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Depressive symptoms
Depressive symptoms will be assessed using the Patient Health Questionnaire-9, developed by Kroenke et al. (2001). This 9-item instrument assesses the frequency of depressive symptoms over the past two weeks. Each item is rated on a 4-point scale, yielding a total severity score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
Baseline and 3 months
Resilience
Resilience will be measured using the Brief Resilience Scale developed by Smith et al. (2008). This 6-item instrument assesses the ability to recover from stress. Each item is rated on a 5-point Likert scale, yielding a total score ranging from 6 to 30, with higher scores indicating greater resilience.
Baseline and 3 months
Secondary Outcomes (3)
Anxiety
Baseline and 3 months
Self-esteem
Baseline and 3 months
Subjective wellbeing
Baseline and 3 months
Study Arms (2)
Intervention Group
EXPERIMENTALParticipants in the intervention group will receive immediate full access to the mental health app services during the study period.
Control Group
OTHERParticipants in the control group will receive basic, without full access to the mental health app services during the study period (active control).
Interventions
Name of the mental health app - Intellect: Create A Better You
Name of mental health app - Intellect: Create a Better You
Eligibility Criteria
You may qualify if:
- Aged 18 to 30;
- Enrolled in medical school (preclinical or clinical years);
- Owns a smartphone;
- Able to read and understand English.
You may not qualify if:
- Does not consent to study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fakulti Perubatan, Universiti Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; Psychiatrist
Study Record Dates
First Submitted
February 2, 2026
First Posted
February 9, 2026
Study Start
February 11, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
February 13, 2026
Record last verified: 2026-02